A carregar...
Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
CONTEXT: Therapeutic doxorubicin administration is restricted as this anticancer drug may be cardiotoxic. The traditional Chinese medicine qiliqiangxin has been approved for clinical treatment of chronic heart failure. OBJECTIVE: To explore the protective effects and molecular mechanisms of qiliqian...
Na minha lista:
| Publicado no: | Pharm Biol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7301709/ https://ncbi.nlm.nih.gov/pubmed/32429724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13880209.2020.1761403 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|